UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000017301
Receipt No. R000020076
Official scientific title of the study The effectiveness of switching from tiotropium/indacaterol to glycopyrronium/indacaterol combination in patients with COPD.
Date of disclosure of the study information 2015/05/01
Last modified on 2018/05/01 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The effectiveness of switching from tiotropium/indacaterol to glycopyrronium/indacaterol combination in patients with COPD.
Title of the study (Brief title) The effectiveness of switching from tiotropium/indacaterol to glycopyrronium/indacaterol combination in patients with COPD.
Region
Japan

Condition
Condition Chronic obstructive pulmonary disease (COPD)
Classification by specialty
Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effectiveness of switching from tiotropium/indacaterol to glycopirronium/indacaterol combination in COPD patients.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change in FEV1 between week 0 and week 8
Key secondary outcomes Change in FVC between week 0 and week 8
Change in FEV1/FVC between week 0 and week 8
Change in FOT parameters between week 0 and week 8
Change in CAT between week 0 and week 8
Change in mMRC between week 0 and week 8

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Switching from tiotropium/indacaterol to glycopirronium/indacaterol combination.
Interventions/Control_2 Continuation of tiotropium/indacaterol.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria -Diagnosis of moderate-to-severe COPD.
-Post-bronchodilator FEV1/FVC < 70%.
-Post bronchodilator FEV1 < 80% predicted normal.
-Smoking history of 10 pack-years or more.
-Patients treated with tiotropium and indacaterol for more than 2 weeks.
Key exclusion criteria -Patients with a history of asthma.
-Patients who are already treated with ICS or oral corticosteroid regularly.
-Patients who have experienced a COPD exacerbation within the previous 8 weeks.
-Patients with uncontrolled cardiac diseases.
Target sample size 60

Research contact person
Name of lead principal investigator Taisuke Akamatsu
Organization Shizuoka General Hospital
Division name Department of Respiratory Medicine
Address 4-27-1 Kita-Ando, Aoi, Shizuoka, 420-8527, Japan
TEL 054-247-6111
Email taisuke-akamatsu@i.shizuoka-pho.jp

Public contact
Name of contact person Taisuke Akamatsu
Organization Shizuoka General Hospital
Division name Department of Respiratory Medicine
Address 4-27-1 Kita-Ando, Aoi, Shizuoka, 420-8527, Japan
TEL 054-247-6111
Homepage URL
Email taisuke-akamatsu@i.shizuoka-pho.jp

Sponsor
Institute Department of Respiratory Medicine, Shizuoka General Hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 05 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 03 Month 27 Day
Anticipated trial start date
2015 Year 05 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 04 Month 28 Day
Last modified on
2018 Year 05 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020076